JPS5649910B2 - - Google Patents

Info

Publication number
JPS5649910B2
JPS5649910B2 JP7164575A JP7164575A JPS5649910B2 JP S5649910 B2 JPS5649910 B2 JP S5649910B2 JP 7164575 A JP7164575 A JP 7164575A JP 7164575 A JP7164575 A JP 7164575A JP S5649910 B2 JPS5649910 B2 JP S5649910B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP7164575A
Other versions
JPS51146463A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP50071645A priority Critical patent/JPS51146463A/ja
Priority to ZA763297A priority patent/ZA763297B/xx
Priority to CA254,089A priority patent/CA1056842A/en
Priority to US05/692,941 priority patent/US4061854A/en
Priority to ES448807A priority patent/ES448807A1/es
Priority to SE7606678A priority patent/SE429756B/xx
Priority to DE19762626293 priority patent/DE2626293A1/de
Priority to DK264876A priority patent/DK264876A/da
Priority to AU14872/76A priority patent/AU500360B2/en
Priority to BE167880A priority patent/BE842893A/fr
Priority to AR263606A priority patent/AR215589A1/es
Priority to CH746076A priority patent/CH602674A5/xx
Priority to FR7617878A priority patent/FR2313919A1/fr
Priority to GB24576/76A priority patent/GB1492236A/en
Priority to NL7606417A priority patent/NL7606417A/xx
Publication of JPS51146463A publication Critical patent/JPS51146463A/ja
Priority to US05/767,633 priority patent/US4139711A/en
Priority to AU43824/79A priority patent/AU511504B2/en
Publication of JPS5649910B2 publication Critical patent/JPS5649910B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/12—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP50071645A 1975-06-12 1975-06-12 A process for preparing ethanoanthracene derivatives Granted JPS51146463A (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
JP50071645A JPS51146463A (en) 1975-06-12 1975-06-12 A process for preparing ethanoanthracene derivatives
ZA763297A ZA763297B (en) 1975-06-12 1976-06-03 Dihydroethanoanthracene derivatives
CA254,089A CA1056842A (en) 1975-06-12 1976-06-04 Dihydroethanoanthracene derivatives
US05/692,941 US4061854A (en) 1975-06-12 1976-06-04 Dihydroethanoanthracene derivatives useful as antidepressants
BE167880A BE842893A (fr) 1975-06-12 1976-06-11 Derives du dihydroethanoanthracene
CH746076A CH602674A5 (ja) 1975-06-12 1976-06-11
DE19762626293 DE2626293A1 (de) 1975-06-12 1976-06-11 9,10-dihydro-9,10-aethanoanthracen- derivate
DK264876A DK264876A (da) 1975-06-12 1976-06-11 Fremgangsmade til fremstilling af dihydroanthracenderivater
AU14872/76A AU500360B2 (en) 1975-06-12 1976-06-11 Dihydroethanoanthracene derivatives
ES448807A ES448807A1 (es) 1975-06-12 1976-06-11 Un procedimiento para preparar derivados de dihidroetanoan- traceno.
AR263606A AR215589A1 (es) 1975-06-12 1976-06-11 Procedimiento para preparar nuevos derivados de dihidroetanantraceno
SE7606678A SE429756B (sv) 1975-06-12 1976-06-11 Forfarande for framstellning av dihydroetanoantracenderivat
FR7617878A FR2313919A1 (fr) 1975-06-12 1976-06-11 Procede de preparation de derives de dihydroethanoanthracene et nouveaux produits ainsi obtenus
GB24576/76A GB1492236A (en) 1975-06-12 1976-06-14 Di-hydroethanoanthracene derivatives
NL7606417A NL7606417A (nl) 1975-06-12 1976-06-14 Dihydroethaanantraceenderivaten.
US05/767,633 US4139711A (en) 1975-06-12 1977-02-10 Dihydroethanoanthracene derivatives
AU43824/79A AU511504B2 (en) 1975-06-12 1979-01-31 Dihydroethanoanthracene derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50071645A JPS51146463A (en) 1975-06-12 1975-06-12 A process for preparing ethanoanthracene derivatives

Publications (2)

Publication Number Publication Date
JPS51146463A JPS51146463A (en) 1976-12-16
JPS5649910B2 true JPS5649910B2 (ja) 1981-11-25

Family

ID=13466561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50071645A Granted JPS51146463A (en) 1975-06-12 1975-06-12 A process for preparing ethanoanthracene derivatives

Country Status (3)

Country Link
JP (1) JPS51146463A (ja)
BE (1) BE842893A (ja)
ZA (1) ZA763297B (ja)

Also Published As

Publication number Publication date
ZA763297B (en) 1977-05-25
JPS51146463A (en) 1976-12-16
BE842893A (fr) 1976-10-01

Similar Documents

Publication Publication Date Title
FR2317852B1 (ja)
JPS5312275B2 (ja)
JPS549876Y2 (ja)
FR2313919B1 (ja)
JPS5637685B2 (ja)
JPS5186168A (ja)
JPS5523179Y2 (ja)
JPS5445436Y2 (ja)
JPS5649910B2 (ja)
JPS5041179Y1 (ja)
JPS5272132U (ja)
JPS526922U (ja)
JPS5190397U (ja)
CH586814A5 (ja)
BG23540A3 (ja)
CH600623A5 (ja)
CH600191A5 (ja)
CH586052A5 (ja)
CH586037A5 (ja)
CH574340A5 (ja)
CH589313A5 (ja)
CH589817A5 (ja)
CH600615A5 (ja)
CH590099A5 (ja)
CH591072A5 (ja)